Supplementary Figure 1.
Mass spectrometry analysis of Asf1a sites phosphorylated by TLK1 in vitro. (a) Coomassie staining of recombinant Asf1a phosphorylated in vitro by recombinant myc-TLK1 wild-type (wt) or kinase-inactive (ki) mutant. The Asf1a band (highlighted by dashed box) with potentially phosphorylated forms was subjected to mass spectrometry analysis (LC-MS/MS). (b-e) MS/MS spectra of the samples described in (a) depicts phosphorylation at the Asf1a peptide containing pS166 (b), pS175 (c), pS192 (d), pS199 (e). Observed b-and y-ions, as well as those resulting from the neutral loss of H 3 PO 4 (-98 Da), are indicated in the spectrum and peptide sequence. C § denotes a carbamidomethylated cysteine, while an oxidized methionine is represented by M ox . 1994.9 In vivo Asf1b pS198, Mascot ion score= 30 . The calculation of pIs were performed using the online tool Scansite for the full-length proteins, N-terminal domains (tailless), and the C-terminal tails. Additionally, pIs of human Asf1 proteins were calculated considering TLK-mediated phosphorylation or substitution with aspartates or glutamates at TLK-target sites (Asf1a: S166, S175, S192, S199 and Asf1b: S169 and S198). 
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